Literature DB >> 1888684

Treatment of major depression with steroid suppressive drugs.

B E Murphy1.   

Abstract

The hypercorticism frequently observed in major depression, unaccompanied by signs of Cushing's syndrome, is still poorly understood. One suicidal young woman, with very high cortisol levels and unusual resistance to dexamethasone suppression, is described. She was successfully treated with steroid suppressive drugs (aminoglutethimide, metyrapone), had a prompt and complete remission and has remained well for more than two years on no medication. This success prompted an on-going clinical trial of this therapy. The available drugs and a working hypothesis of their action are discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1888684     DOI: 10.1016/0960-0760(91)90069-h

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  11 in total

Review 1.  [New developments in pharmacotherapy of depression].

Authors:  R Rupprecht; Th C Baghai; H-J Möller
Journal:  Nervenarzt       Date:  2003-05-10       Impact factor: 1.214

Review 2.  Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators.

Authors:  Bruce S McEwen
Journal:  Eur J Pharmacol       Date:  2008-01-30       Impact factor: 4.432

Review 3.  Glucocorticoid inhibition in the treatment of depression: can we think outside the endocrine hypothalamus?

Authors:  Mitchel A Kling; Victoria H Coleman; Jay Schulkin
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

4.  Developments in psychoneuroendocrinology: a tribute to the research of Robert A Cleghorn, 1904-1995.

Authors:  S N Young
Journal:  J Psychiatry Neurosci       Date:  1995-07       Impact factor: 6.186

Review 5.  Hormone treatment of depression.

Authors:  Russell T Joffe
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

6.  Antiglucocorticoids as Treatments for Depression : Rationale for Use and Therapeutic Potential.

Authors:  L H Price; R T Malison; C J McDougle; G H Pelton
Journal:  CNS Drugs       Date:  1996-05       Impact factor: 5.749

7.  Strain-specific steroidal control of pituitary function.

Authors:  Sang-Nam Lee; Bonnie Peng; Roxane Desjardins; John E Pintar; Robert Day; Iris Lindberg
Journal:  J Endocrinol       Date:  2007-03       Impact factor: 4.286

8.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

Authors:  B E Murphy; D Filipini; A M Ghadirian
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

Review 9.  Innovative approaches for the treatment of depression: targeting the HPA axis.

Authors:  Fiona Thomson; Mark Craighead
Journal:  Neurochem Res       Date:  2007-10-25       Impact factor: 3.996

10.  Metyrapone in treatment-resistant depression.

Authors:  Paul David Sigalas; Himanshu Garg; Stuart Watson; Richard Hamish McAllister-Williams; I Nicol Ferrier
Journal:  Ther Adv Psychopharmacol       Date:  2012-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.